Efficacy of Using NLR and IL-6 as Outcome Predictors of HCC

Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer-related death. Percutaneous ethanol injection (PEI) and radio frequency ablation (RFA) techniques became well-known procedures for controlling small HCC. Inflammation is a major contributing factor to carcinogenesis specially HCC. Inflammatory mediators including interleukin- 6 (IL-6) and neutrophil to lymphocyte ratio (NLR) are good candidates to stimulate tumor growth and progression.

Autorentext

Current status:-- Lecturer in the Department of Tropical Medicine (Gastroenterology, Hepatology and Infectious Diseases), Faculty of Medicine Zagazig University,EGYPT. Education:-- M.D.in Tropical Medicine. - M.Sc. in Tropical Medicine.- Bachelor of Medicine and General Surgery(M.B., B.Ch.), excellence with Honor.